356 related articles for article (PubMed ID: 28471826)
21. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.
Bassi A; Dodd S; Williamson P; Bodger K
Gut; 2004 Oct; 53(10):1471-8. PubMed ID: 15361497
[TBL] [Abstract][Full Text] [Related]
22. [Integrated management of patients with chronic inflammatory bowel disease in the Rhine-Main Region: results of the first integrated health-care project IBD in Germany].
Blumenstein I; Tacke W; Filmann N; Zosel C; Bock H; Heuzeroth V; Zeuzem S; Schröder O
Z Gastroenterol; 2013 Jul; 51(7):613-8. PubMed ID: 23696113
[TBL] [Abstract][Full Text] [Related]
23. Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database.
Huber CA; Agosti R; Näpflin M; Blozik E
Pharmacoepidemiol Drug Saf; 2020 Mar; 29(3):279-287. PubMed ID: 31828875
[TBL] [Abstract][Full Text] [Related]
24. Cost of Illness in Inflammatory Bowel Disease.
Kamat N; Ganesh Pai C; Surulivel Rajan M; Kamath A
Dig Dis Sci; 2017 Sep; 62(9):2318-2326. PubMed ID: 28766243
[TBL] [Abstract][Full Text] [Related]
25. Urolithiasis and urinary tract infection among patients with inflammatory bowel disease: a review of US emergency department visits between 2006 and 2009.
Varda BK; McNabb-Baltar J; Sood A; Ghani KR; Kibel AS; Letendre J; Menon M; Sammon JD; Schmid M; Sun M; Trinh QD; Bhojani N
Urology; 2015 Apr; 85(4):764-70. PubMed ID: 25669736
[TBL] [Abstract][Full Text] [Related]
26. Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study.
Moisset X; Bommelaer G; Boube M; Ouchchane L; Goutte M; Dapoigny M; Dallel R; Guttmann A; Clavelou P; Buisson A
Eur J Pain; 2017 Oct; 21(9):1550-1560. PubMed ID: 28508514
[TBL] [Abstract][Full Text] [Related]
27. The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory.
Pagano E; De Rosa M; Rossi E; Cinconze E; Marchesini G; Miccoli R; Vaccaro O; Bonora E; Bruno G
Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):944-50. PubMed ID: 27289165
[TBL] [Abstract][Full Text] [Related]
28. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.
Weng X; Liu L; Barcellos LF; Allison JE; Herrinton LJ
Am J Gastroenterol; 2007 Jul; 102(7):1429-35. PubMed ID: 17437504
[TBL] [Abstract][Full Text] [Related]
29. Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease.
Kaplan GG; Hubbard J; Panaccione R; Shaheen AA; Quan H; Nguyen GC; Dixon E; Ghosh S; Myers RP
Arch Surg; 2011 Aug; 146(8):959-64. PubMed ID: 21844437
[TBL] [Abstract][Full Text] [Related]
30. Multiple chronic conditions at a major urban health system: a retrospective cross-sectional analysis of frequencies, costs and comorbidity patterns.
Majumdar UB; Hunt C; Doupe P; Baum AJ; Heller DJ; Levine EL; Kumar R; Futterman R; Hajat C; Kishore SP
BMJ Open; 2019 Oct; 9(10):e029340. PubMed ID: 31619421
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
[TBL] [Abstract][Full Text] [Related]
32. Frequency of use and cost of biologic treatment for inflammatory bowel disease and inflammatory bowel disease-associated arthropathy in Colombia in 2019.
Fernández-Ávila DG; Dávila-Ruales V
Rev Gastroenterol Mex (Engl Ed); 2024; 89(2):213-221. PubMed ID: 37208212
[TBL] [Abstract][Full Text] [Related]
33. Epithelial Dysplasia and Cancer in IBD Strictures.
Sonnenberg A; Genta RM
J Crohns Colitis; 2015 Sep; 9(9):769-75. PubMed ID: 26079724
[TBL] [Abstract][Full Text] [Related]
34. Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.
Limsrivilai J; Stidham RW; Govani SM; Waljee AK; Huang W; Higgins PD
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):385-392.e2. PubMed ID: 27645518
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory bowel diseases: health care and costs in Sweden in 1994.
Blomqvist P; Ekbom A
Scand J Gastroenterol; 1997 Nov; 32(11):1134-9. PubMed ID: 9399395
[TBL] [Abstract][Full Text] [Related]
36. Heat waves, incidence of infectious gastroenteritis, and relapse rates of inflammatory bowel disease: a retrospective controlled observational study.
Manser CN; Paul M; Rogler G; Held L; Frei T
Am J Gastroenterol; 2013 Sep; 108(9):1480-5. PubMed ID: 23939628
[TBL] [Abstract][Full Text] [Related]
37. Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.
Ritzwoller DP; Ellis JL; Korner EJ; Hartsfield CL; Sadosky A
Curr Med Res Opin; 2009 Jun; 25(6):1319-28. PubMed ID: 19419344
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review.
Park KT; Bass D
Inflamm Bowel Dis; 2011 Jul; 17(7):1603-9. PubMed ID: 21053357
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of chronic narcotic use among children with inflammatory bowel disease.
Buckley JP; Cook SF; Allen JK; Kappelman MD
Clin Gastroenterol Hepatol; 2015 Feb; 13(2):310-315.e2. PubMed ID: 25117776
[TBL] [Abstract][Full Text] [Related]
40. The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: a single metropolitan Australian center experience.
van Langenberg DR; Simon SB; Holtmann GJ; Andrews JM
J Crohns Colitis; 2010 Oct; 4(4):413-21. PubMed ID: 21122537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
